This study shows that smoking worsens neovascular age-related macular degeneration via the Sema4D-PlexinB1 pathway. Targeting Sema4D reduces choroidal neovascularization and enhances anti-VEGF ...

A 2024 study, performed at Southern Medical University in Guangzhou, China, showed that microplastics are detected commonly in human vitreous ... Age-related macular degeneration too has been ...

Frontotemporal lobar degeneration (FTLD) is a neurodegenerative disease affecting the frontal and temporal lobes that regulate higher cognitive brain functions such as personality, behavior ...

Diseases such as neovascular age-related macular degeneration (nAMD), myopic maculopathy ... He is a partner and Director of Research at Retina Vitreous Associates of Florida, where he has ...

Ken McKay/ITV/Shutterstock A woman who can smell Parkinson’s disease is using her hyperosmia — an enhanced sense of smell — to help diagnose the degenerative disease early as part of a study ...

Gage faces a degenerative neurological disorder that necessitates frequent hospital visits and treatments at facilities like Johns Hopkins and Mayo Clinic. The family moved to Nicholasville in ...

Vitrectomy is a surgical procedure for severe or treatment-resistant DME. It involves removing the vitreous humor to treat structural changes causing macular swelling. This procedure may help ...

Conditions such as retinitis pigmentosa and age-related macular degeneration involve the irreversible loss of light-sensitive neural cells in the retina. While current treatments may slow ...

Posterior vitreous detachment (PVD) occurs when the vitreous—a gel-like fluid in the eye—detaches from the retina. This results in eye floaters and flashes of light that can be annoying but is usually ...

In mice both with retinitis pigmentosa (RP) and lab-grown human retina tissue with damage akin to age-related macular degeneration (AMD), a daily drop prevented photoreceptors in the eye from ...

A New Jersey-based biotech is looking to become the main character in the age-related macular degeneration field. Character Biosciences has landed a $93 million series B to progress its precision ...

“Millions of patients suffering from degenerative eye diseases lack effective treatments that delay disease progression,” said Cheng Zhang, CEO & Co-Founder, Character Biosciences. “By ...